×
About 2,070 results

ALLMedicine™ Endometrial Cancer Center

Research & Reviews  811 results

Clinicopathologic association and prognostic impact of microcystic, elongated and fragm...
https://doi.org/10.1111/jog.15335
The Journal of Obstetrics and Gynaecology Research; Qi X, Zhu L et. al.

Jul 1st, 2022 - As a special invasive pattern seen in low-grade endometrial carcinoma, microcystic, elongated and fragmented (MELF) pattern is related to lymph node metastasis. Tumor budding (TB) is another histological marker in many cancers associated with tumo...

The roles and therapeutic applications of cytokines in endometrial cancer.
https://doi.org/10.1016/j.jri.2022.103652
Journal of Reproductive Immunology; Azadehrah M, Vosoogh S et. al.

Jun 27th, 2022 - Endometrial cancer (EC) is a common gynecological cancer globally and the most frequent gynecologic malignancy in industrialized countries. Patients are typically diagnosed when the disease is still restricted to the uterus. 5-year overall surviva...

Glycosylation and its research progress in endometrial cancer.
https://doi.org/10.1007/s12094-022-02858-z 10.1002/ijc.33857 10.3322/caac.21708 10.1093/jnci/djx214 10.1016/j.ygyno.2021.01.036 10.1016/j.ygyno.2013.02.018 10.3322/caac.21551 10.1093/glycob/11.10.119R 10.1021/jo050278f 10.1080/0284186X.2018.1540886 10.1002/prca.201800099 10.1038/nrc1649 10.1038/nrc3982 10.1002/pmic.201300387 10.1002/anie.201900995 10.1038/s41589-019-0323-5 10.4149/gpb_2016039 10.1038/s41418-021-00740-z 10.1016/j.cub.2019.01.003 10.1097/00000441-194902000-00011 10.1515/BC.2009.043 10.1016/j.critrevonc.2017.12.006 10.1016/S0168-8278(00)80099-9 10.2174/1568009033481714 10.1093/jb/mvn011 10.1016/bs.acr.2014.11.002 10.1111/tan.12900 10.1126/science.2953071 10.1002/1615-9861(200102)1:2<285::AID-PROT285>3.0.CO;2-G 10.1016/bs.pmbts.2019.01.005 10.18632/oncotarget.15994 10.1007/s12253-015-0030-9 10.1039/C6AN02715F 10.1586/14789450.2016.1172965 10.1134/S0006297913070031 10.1039/C3AN01813J 10.1002/mrd.22794 10.1038/srep37189 10.21037/atm-20-3504 10.1021/pr400169n 10.1021/pr201070k 10.1021/acs.jproteome.5b01071 10.1007/s00216-020-03039-z 10.18632/oncotarget.15994 10.1038/s41419-018-1101-0 10.1016/j.ygyno.2005.07.016 10.3109/13813455.2016.1151441 10.1158/1078-0432.CCR-05-0461 10.3390/ijms13089489 10.1038/s41374-020-0411-x 10.3389/fonc.2020.01218 10.3389/fonc.2020.540332 10.1096/fj.201901793R 10.1021/acs.jproteome.6b00548 10.1016/j.jprot.2017.02.001 10.1515/cclm-2012-0642 10.3390/biom5031741 10.1007/s10585-019-09966-1 10.1016/j.cell.2005.09.041 10.1126/science.1102109 10.1073/pnas.0507659102 10.1073/pnas.1107385108 10.1007/s00018-010-0595-0 10.2174/1568009620666201116113334 10.1023/A:1006756518500 10.1084/jem.182.2.419 10.1093/glycob/7.2.221 10.1016/j.jsbmb.2016.02.015 10.1042/CS20190145 10.1016/j.biopha.2020.110764 10.1186/s13058-017-0904-8 10.1073/pnas.1220425110 10.7150/thno.56882 10.1073/pnas.1406619111 10.1126/science.6729450 10.3390/ijms17030275 10.1016/j.bbagen.2005.12.022 10.1093/humupd/dmu037 10.1093/humupd/5.4.330 10.1159/000486770 10.1016/j.mce.2011.10.029 10.1016/j.mce.2011.10.029 10.18632/aging.104142 10.2174/0929867328666210705144456 10.1016/j.canlet.2014.09.003 10.1007/s10552-011-9794-8 10.1007/s00520-016-3554-y 10.3389/fendo.2021.780769 10.1002/(SICI)1098-2744(200001)27:1<2::AID-MC2>3.0.CO;2-W 10.1016/0143-4004(91)90496-3 10.1111/IGC.0b013e3181b33be0 10.1074/mcp.M900430-MCP200 10.1093/glycob/cwz084 10.1016/j.ejogrb.2013.04.016 10.1186/s13046-018-0696-4 10.1023/A:1006464409137 10.1126/science.291.5512.2370 10.1073/pnas.172380699 10.1038/nrd1751 10.1016/j.ymthe.2017.05.012 10.1093/infdis/jiz643 10.4049/jimmunol.174.9.5706 10.1007/s10719-012-9437-7 10.1007/s00262-006-0274-z 10.3389/fimmu.2019.02120 10.1016/S1470-2045(13)70591-6 10.1038/modpathol.2015.43 10.1002/cncr.30496 10.1038/s41568-019-0177-x 10.1016/bs.acr.2014.12.002 10.1007/s13277-015-3544-6 10.1186/1471-2407-13-616 10.1073/pnas.152127499 10.1111/his.12107 10.2174/092986709789352277 10.1158/0008-5472.CAN-12-2072 10.1021/jm049693a 10.1021/jm101024j 10.1021/jm2017336 10.1021/jacs.6b06937 10.1021/jm8015409 10.1186/s12943-018-0801-5 10.1016/S0140-6736(15)00130-0 10.1158/0008-5472.CAN-18-0505 10.1158/1078-0432.CCR-18-0792 10.1016/j.carbpol.2021.118323 10.1007/s10439-011-0333-2 10.1016/j.biomaterials.2012.08.043 10.1016/j.jconrel.2015.05.003 10.1007/978-1-60761-609-2_3 10.1124/jpet.118.255372 10.1038/s41580-020-00294-x 10.1007/s13238-018-0597-5 10.3233/CBM-2012-0226 10.1586/14789450.2014.897611 10.1016/bs.ircmb.2018.05.014 10.1093/glycob/cwy008 10.1016/j.smim.2018.05.003 10.1126/science.1235681 10.1038/sj.bjc.6605083 10.1073/pnas.96.10.5710 10.1016/j.bbcan.2020.188464 10.1200/JCO.2005.13.011 10.2174/156800906778194577 10.1158/1078-0432.CCR-05-1574 10.1016/j.cellimm.2004.12.007 10.1158/1078-0432.CCR-04-0347 10.1016/j.jprot.2017.09.014 10.1021/acs.analchem.6b03365
Clinical & Translational Oncology : Official Publication ... Pu C, Biyuan et. al.

Jun 26th, 2022 - Endometrial cancer (EC) is one of the most common tumors in the female reproductive system, which seriously threatens women's health, particularly in developed countries. 13% of the patients with EC have a poor prognosis due to recurrence and meta...

see more →

Guidelines  1 results

Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial...
https://doi.org/10.1002/jso.25797
Journal of Surgical Oncology REFERENCES; Ribeiro R, Fontes Cintra G et. al.

Dec 18th, 2019 - Approximately 70% of cancer-related deaths occur in low- and middle-income countries. In addition to social and racial inequalities, treatment options in these countries are usually limited because of the lack of trained staff and equipment, limit...

see more →

Drugs  1 results see all →

News  14 results

Transvaginal US May Miss Black Women Who Should Be Tested for Endometrial Cancer
https://www.medscape.com/viewarticle/955115

Jul 21st, 2021 - NEW YORK (Reuters Health) - Endometrial thickness (ET) as measured by transvaginal ultrasound (TVUS) is an unreliable indicator of a Black woman's need for a biopsy and may exacerbate racial disparities in endometrial cancer (EC) stage at diagnosi...

BRCA1/2 Mutations Raise Risk for Endometrial Cancer, Too
https://www.medscape.com/viewarticle/948530

Apr 2nd, 2021 - NEW YORK (Reuters Health) - Women with a BRCA1 or BRCA2 mutation have an increased risk for endometrial cancer (EC), and the greatest risk is for the rare subgroup of serous-like and p53-abnormal endometrial cancers in BRCA1 mutation carriers, acc...

Targeted sequencing panel IDs Lynch syndrome in women with/at risk for endometrial cancer
https://www.mdedge.com/fedprac/avaho/article/201466/gynecologic-cancer/targeted-sequencing-panel-ids-lynch-syndrome-women?channel=263
Sharon Worcester

May 22nd, 2019 - NASHVILLE, TENN. – A targeted next-generation sequencing panel rapidly identifies both germline and somatic Lynch syndrome pathogenic mutations in women with – or at risk for – endometrial cancer, according to findings in a prospective patient coh.

Two Surgeries at Once: Endometrial Cancer & Stress Incontinence
https://www.medscape.com/viewarticle/910918

Mar 26th, 2019 - HONOLULU, Hawaii — Women who require surgery for endometrial cancer and who choose to also have surgery to treat concomitant stress urinary incontinence (SUI) are significantly more likely to enjoy a better quality of life (QoL) at 6 months than w...

Postmenopausal Bleeding Requires More Than Blind Biopsy
https://www.medscape.com/viewarticle/888432

Nov 13th, 2017 - PHILADELPHIA — Clinicians should regard postmenopausal bleeding as endometrial cancer "until proven otherwise" and recognize that blind biopsies alone are insufficient to rule out cancer, according to a presentation here at the North American Meno...

see more →

Patient Education  1 results see all →